Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nylstar is a Spanish materials science company specializing in the production of high-performance polyamide 6.6 fibers and yarns, most notably under the Meryl brand. While primarily a textile manufacturer, the company serves the healthcare industry through its development of medical-grade textiles and antimicrobial fibers like Meryl Skinlife. These specialized fibers are used in the production of compression garments, orthopedic supports, and hygienic medical apparel to inhibit bacterial growth and maintain skin health. Nylstar's technology focuses on embedding functional properties, such as silver ions for bacteriostatic effects, directly into the fiber matrix during the extrusion process. The company operates a large-scale manufacturing facility in Blanes, Spain, and emphasizes sustainable, zero-discharge production processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nylstar.